USA. Stalemate breaks on telehealth prescriptions of stimulants and addiction treatment - DEA allows one-year extension of flexibility given health providers during pandemic
USA. Stalemate breaks on telehealth prescriptions of stimulants and addiction treatment - DEA allows one-year extension of flexibility given health providers during pandemic
Federal officials on Friday said health providers could prescribe drugs for opioid addiction and ADHD over telehealth for one more year, ending a months-long stalemate among policymakers.
During the pandemic, the Drug Enforcement Agency issued temporary rules that allowed providers to prescribe controlled substances like buprenorphine and Adderall without first meeting a patient in person. Those rules were set to expire on Jan. 1, and have now been extended until the end of 2025. (Stat News, USA, 15.11.2024)
https://www.statnews.com/2024/11/15/telehealth-prescriptions-adderall-buprenorphine-prescriptions/